How to buy OptimizeRx Corporation stock

OptimizeRx Corporation is a health information services business based in the US. OptimizeRx Corporation shares (OPRX) are listed on the NASDAQ and all prices are listed in US Dollars. OptimizeRx Corporation employs 70 staff and has a trailing 12-month revenue of around USD$34.3 million.

How to buy shares in OptimizeRx Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for OptimizeRx Corporation. Find the stock by name or ticker symbol: OPRX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OptimizeRx Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OptimizeRx Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of OptimizeRx Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OptimizeRx Corporation share price

Use our graph to track the performance of OPRX stocks over time.

OptimizeRx Corporation shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$6.5019 - USD$63.98
50-day moving average	USD$47.3673
200-day moving average	USD$28.6406
Wall St. target price	USD$61.33
PE ratio	247.0732
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$0.041

Buy OptimizeRx Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy OptimizeRx Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of OptimizeRx Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OptimizeRx Corporation financials

Revenue TTM	USD$34.3 million
Gross profit TTM	USD$15.4 million
Return on assets TTM	-5.18%
Return on equity TTM	-12.64%
Profit margin	-16.19%
Book value	$3.097
Market capitalisation	USD$924.6 million

TTM: trailing 12 months

Shorting OptimizeRx Corporation shares

There are currently 1.0 million OptimizeRx Corporation shares held short by investors – that's known as OptimizeRx Corporation's "short interest". This figure is 4.1% up from 988,890 last month.

There are a few different ways that this level of interest in shorting OptimizeRx Corporation shares can be evaluated.

OptimizeRx Corporation's "short interest ratio" (SIR)

OptimizeRx Corporation's "short interest ratio" (SIR) is the quantity of OptimizeRx Corporation shares currently shorted divided by the average quantity of OptimizeRx Corporation shares traded daily (recently around 189255.88235294). OptimizeRx Corporation's SIR currently stands at 5.44. In other words for every 100,000 OptimizeRx Corporation shares traded daily on the market, roughly 5440 shares are currently held short.

However OptimizeRx Corporation's short interest can also be evaluated against the total number of OptimizeRx Corporation shares, or, against the total number of tradable OptimizeRx Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OptimizeRx Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 OptimizeRx Corporation shares in existence, roughly 70 shares are currently held short) or 0.0706% of the tradable shares (for every 100,000 tradable OptimizeRx Corporation shares, roughly 71 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against OptimizeRx Corporation.

Find out more about how you can short OptimizeRx Corporation stock.

Have OptimizeRx Corporation's shares ever split?

OptimizeRx Corporation's shares were split on a 1:3 basis on 14 May 2018. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OptimizeRx Corporation shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for OptimizeRx Corporation shares which in turn could have impacted OptimizeRx Corporation's share price.

OptimizeRx Corporation share price volatility

Over the last 12 months, OptimizeRx Corporation's shares have ranged in value from as little as $6.5019 up to $63.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptimizeRx Corporation's is 0.6435. This would suggest that OptimizeRx Corporation's shares are less volatile than average (for this exchange).

OptimizeRx Corporation overview

OptimizeRx Corporation operates as a digital health company that facilitates communication at point-of-care among various stakeholders in healthcare. Its cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, and critical clinical information; and network consists of electronic health record company platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and clinical messaging services. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

Frequently asked questions

• What percentage of OptimizeRx Corporation is owned by insiders or institutions?

  Currently 17.906% of OptimizeRx Corporation shares are held by insiders and 65.755% by institutions.

• How many people work for OptimizeRx Corporation?

  Latest data suggests 70 work at OptimizeRx Corporation.

• When does the fiscal year end for OptimizeRx Corporation?

  OptimizeRx Corporation's fiscal year ends in December.

• Where is OptimizeRx Corporation based?

  OptimizeRx Corporation's address is: 400 Water Street, Rochester, MI, United States, 48307

• What is OptimizeRx Corporation's ISIN number?

  OptimizeRx Corporation's international securities identification number is: US68401U2042

• What is OptimizeRx Corporation's CUSIP number?

  OptimizeRx Corporation's Committee on Uniform Securities Identification Procedures number is: 68401U105